Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Cash & Current Investments (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Cash & Current Investments for 16 consecutive years, with $733.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 186.35% to $733.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $733.5 million through Dec 2025, up 186.35% year-over-year, with the annual reading at $733.5 million for FY2025, 186.35% up from the prior year.
  • Cash & Current Investments hit $733.5 million in Q4 2025 for Ligand Pharmaceuticals, up from $664.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $733.5 million in Q4 2025 to a low of $38.3 million in Q2 2024.
  • Historically, Cash & Current Investments has averaged $269.2 million across 5 years, with a median of $232.0 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: plummeted 82.52% in 2024 and later surged 788.97% in 2025.
  • Year by year, Cash & Current Investments stood at $341.1 million in 2021, then tumbled by 37.89% to $211.9 million in 2022, then decreased by 19.62% to $170.3 million in 2023, then skyrocketed by 50.41% to $256.2 million in 2024, then soared by 186.35% to $733.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for LGNDZ at $733.5 million in Q4 2025, $664.5 million in Q3 2025, and $245.0 million in Q2 2025.